+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Contribution of angiogenic factors in a rat model of pre-eclampsia



Contribution of angiogenic factors in a rat model of pre-eclampsia



American Journal of Nephrology 32(4): 332-339



Pre-eclampsia is a disorder that results in significant feto-maternal complications with yet no definitive pharmacologic intervention. One postulated etiologic mechanism is an imbalance between circulating pro-angiogenic and anti-angiogenic factors. We investigated these factors sequentially throughout pregnancy (19-21 days) in our rat model of pre-eclampsia, which involves the imposition of excessive volume expansion. We evaluated the status of the pro-angiogenic and anti-angiogenic factors at the following time points: 3-5, 7-10 and 17-20 days of gestation. We have previously determined that the urinary excretion of the circulating bufodienolide, marinobufagenin, is elevated at the 3- to 5-day time period, prior to the advent of hypertension and proteinuria. At 3-5 days of pregnancy, there was no evidence of angiogenic imbalance in the normal pregnant (NP) and 'pre-eclamptic' (PDS) rats. At the 7- to 10-day time point, plasma PlGF was greater in the NP rats than in the PDS group (p < 0.05). The plasma sFlt-1/PlGF ratio in the PDS animals was greater than that in the NP rats (p < 0.05). The placental sFlt-1 and sFlt-1/PlGF ratio were greater in the PDS rats than in NP rats (p < 0.05). These changes were also present at the 17- to 20-day time point in both plasma and placenta. The administration of resibufogenin, an antagonist of marinobufagenin, early in pregnancy, prevented angiogenic imbalance. We conclude that angiogenic imbalance plays a role in the pathogenesis of pre-eclampsia in this rat model. Furthermore, the earliest event in the pathogenetic sequence appears to be the secretion and elaboration of marinobufagenin.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052327651

Download citation: RISBibTeXText

PMID: 20720407

DOI: 10.1159/000319463


Related references

Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovascular Journal of Africa 24(5): 174-179, 2013

Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia. Gynecological Endocrinology 28(8): 628-632, 2012

The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia. Cardiovascular Journal of Africa 23(3): 153-159, 2012

Angiogenic factors can be used when pre-eclampsia is suspected. Ugeskrift for Laeger 177(22): V11140638, 2015

The role of angiogenic factors in pre-eclampsia. Pregnancy Hypertension 4(3): 246, 2014

W220 Angiogenic Factors In Predicting Pre-Eclampsia. International Journal of Gynecology & Obstetrics 119: S776-S777, 2012

Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. Bjog 120(10): 1215-1223, 2013

Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. Bjog 121(4): 507, 2014

Angiogenic factors and pre-eclampsia: an early marker is needed. Clinical Science 116(3): 231-232, 2009

Angiogenic factors in pre-eclampsia: implications for clinical practice. Bjog 125(11): 1396, 2018

Circulating angiogenic and antiangiogenic factors in women with eclampsia. American Journal of Obstetrics and Gynecology 204(2): 152.E1-9, 2011

Role of angiogenic factors in the pathogenesis and management of pre-eclampsia. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 141(1): 5, 2018

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clinical Science 122(2): 43-52, 2012

Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. National Medical Journal of India 23(2): 77-81, 2010

Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Journal of Maternal-Fetal and Neonatal Medicine 29(4): 537-543, 2016